ENTRY       D05146                      Drug
NAME        Nerelimomab (USAN/INN)
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG01936  TNF inhibitor
EFFICACY    Immunosuppressant, TNF inhibitor
  TYPE      Monoclonal antibody
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
  PATHWAY   hsa04010(7124)  MAPK signaling pathway
            hsa04060(7124)  Cytokine-cytokine receptor interaction
            hsa04210(7124)  Apoptosis
            hsa04350(7124)  TGF-beta signaling pathway
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG01936  TNF inhibitor
                D05146  Nerelimomab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D05146  Nerelimomab (USAN/INN)
DBLINKS     CAS: 162774-06-3
            PubChem: 47206870
///
